It might even lead to other complications such as arrhythmias, rupture of the papillary muscles of the heart, or sudden death.Medical community has various modalities to detect CAD and examine its extent. Apart from history and clinical examination, noninvasive methods include Electrocardiography (ECG) (at rest or during exercise) and chest X-ray. Echocardiography can provide useful information on the functioning of myocardium, as the enlargement of Left Ventricle , the Ejection Fraction and the situation of heart valves. The best modalities to accurately detect CAD though are the coronary angiogram and the Coronary CT angiography. Angiogram can provide detailed anatomy of coronary circulation and lesions albeit not perfect. Significance of each lesions is determined by the diameter loss. Diameter loss of 50% translates to a 75% cross-sectional area loss which is considered moderate, by most groups. Severe stenosis is considered when the diameter loss is 2/3 of original diameter or more, that is 90% loss of cross-sectional area loss or more. To determine the severity of stenosis more accurately, interventional cardiologists might also employ Intravascular ultrasound. Intravascular ultrasound utilizes ultrasound technology to determine the severity of stenosis and provide information on the composition of the atheromatic plaque. Fractional flow reserve also can be of use. With FFR, the post-stenotic pressure is compared to mean aortic pressure. If the value is <0,80, then the stenosis is deemed significant. Indications for CABG
Stable patients
People suffering from angina during exercise are usually first treated with  medical therapy.
It is indicated for the treatment of inborn errors in primary bile-acid synthesis due to 3β-hydroxy-Δ5-C27-steroid oxidoreductase deficiency or Δ4-3-oxosteroid-5β-reductase deficiency in infants, children and adolescents aged one month to 18 years and adults.Cholic acid FGK (Kolbam) was approved for medical use in the European Union in November 2015. It is indicated for the treatment of inborn errors of primary bile acid synthesis, in infants from one month of age for continuous lifelong treatment through adulthood, encompassing the following single enzyme defects:
sterol 27-hydroxylase deficiency (presenting as cerebrotendinous xanthomatosis, CTX);
2- (or alpha-) methylacyl-CoA racemase (AMACR) deficiency;
cholesterol 7 alpha-hydroxylase (CYP7A1) deficiency.The most common side effects include peripheral neuropathy (nerve damage in the hands and feet), diarrhea, nausea (feeling sick), acid reflux (stomach acid flowing up into the mouth), esophagitis (inflammation of the food pipe), jaundice (yellowing of the skin and eyes), skin problems (lesions) and malaise (feeling unwell). Interactive pathway map
Click on genes, proteins and metabolites below to link to respective articles. References
External links
"Cholic acid". Drug Information Portal. U.S. National Library of Medicine.